The CD81 partner EWI-2wint inhibits hepatitis C virus entry

PLoS ONE

Volumn 3, Issue 4, 2008, Pages

  Rocha Perugini, Vera ^a   Montpellier, Claire ^a   Delgrange, David ^a   Wychowski, Czeslaw ^a   Helle, François ^a   Pillez, André ^a   Drobecq, Hervé ^a   Le Naour, François ^c   Charrin, Stéphanie ^c   Levy, Shoshana ^b   Rubinstein, Eric ^c   Dubuisson, Jean ^a   Cocquerel, Laurence ^a,b  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; PROTEIN EWI 2WINT; TETRASPANIN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; GLYCOPROTEIN; IGSF8 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CELL STRAIN COS7; CHO CELL; CONTROLLED STUDY; FETUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; INHIBITION KINETICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VIRUS CELL INTERACTION; VIRUS ENTRY; AMINO ACID SEQUENCE; ANIMAL; CELL MEMBRANE; CELL STRAIN COS1; CELL STRAIN U937; CERCOPITHECUS; CHEMISTRY; CRICETULUS; HAMSTER; LIVER CELL; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

HEPATITIS C VIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; CRICETULUS; GLYCOPROTEINS; HEPACIVIRUS; HEPATOCYTES; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; U937 CELLS;

EID: 44849100946     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001866     Document Type: Article

References (51)

1. Lemon SM, Walker C, Alter MJ, Yi M (2007) Hepatitis C Virus. In: Knipe DM, Howley PM, eds. Fields Virology. Fifth ed. Philadelphia: Lippincott Williams & Wilkins. pp 1253-1304.
2. Manns MP, Wedemeyer H, Cornberg M (2006) Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55: 1350-1359.
3. Bartosch B, Dubuisson J, Cosset F-L (2003) Highly infectious hepatitis C pseudo-viruses containing functional E1E2 envelope protein complexes. J Exp Med 197: 633-642.
4. Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, et al. (2003) Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 100: 7271-7276.
5. Lindenbach BD, Evans MJ, Syder AJ, Walk B, Tellinghuisen TL, et al. (2005) Complete replication ofhepatitis C virus in cell culture. Science 309: 623-626.
6. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
7. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102: 9294-9299.
8. Op De Beeck A, Cocqucrel L, Dubuisson J (2001) Biogenesis of hepatitis C virus envelope glycoproteins. J Gen Virol 82: 2589-2595.
9. Dubuisson J, Helle F, Cocquerel L (2007) Early steps of the hepatitis C virus life cycle. Cell Microbiol in press.
10. Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, et al. (2003) Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 278: 41624-41630.
11. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Parris M, et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446: 801-805.
12. Zheng A, Yuan F, Li Y, Zhu F, Hou P, et al. (2007) Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus. J Virol 81: 12465-12471.
13. Yang W, Qiu C, Biswas N, Jin J, Watkini SC, et al. (2008) Correlation of the tight junction-like distribution of claudin-1 to the cellular tropism of HCV. J Biol Chem.
14. Boucheix C, Rubinstein E (2001) Tetraspanins. Cell Mot Life Sci 58: 1189-1205.
15. Levy S, Shoham T (2005) The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 5: 136-148.
16. Levy S, Shoham T (2005) Protein-protein interactions in the tetraspanin web. Physiology (Bethesda) 20: 218-224.
17. Rubinstein E, Le Naour F, Lagaudriere-Gesbert C, Billard M, Conjeaud H, et al. (1996) CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 26: 2657-2665.
18. Charrin S, Le Naour F, Labas V, Billard M, Le Caer JP, et al. (2003) EWI-2 is a new component of the tetraspanin web in hcpatocytes and lymphoid cells. Biochem J 373: 409-421.
19. Charrin S, Le Naour F, Oualid M, Billard M, Faure G, et al. (2001) The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem 276: 14329-14337.
20. Clark KL, Zeng Z, Langford AL, Bowen SM, Todd SC (2001) PGRL is a major CD81-associated protein on lymphocytes and distinguishes a new family of cell surface proteins. J Immunol 167: 5115-5121.
21. Stipp CS, Kolesnikova TV, Hemler ME (2001) EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily. J Biol Chem 276: 40545-40554.
22. Stipp CS, Orlicky D, Hemler ME (2001) FPRP, a major, highly stoichiometric, highly specific CD81- and CD9- associated protein. J Biol Chem 276: 4853-4862.
23. Sala-Valdes M, Ursa A, Charrin S, Rubinstein E, Hemler ME, et al. (2006) EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins. J Biol Chem 281: 19665-19675.
24. Kolesnikova TV, Stipp CS, Rao RM, Lane WS, Luscinskas FW, et al. (2004) EWI-2 modulates lymphocyte integrin alpha4beta1 functions. Blood 103: 3013-3019.
25. Stipp CS, Kolesnikova TV, Hemler ME (2003) EWI-2 regulates alpha3beta1 integrin-dependent cell functions on laminin-5. J Cell Biol 183: 1167-1177.
26. Zhang XA, Lane WS, Charrin S, Rubinstein E, Liu L (2003) EWI12/PGRL associates with the metastasis suppressor KAI/CD82 and inhibits the migration of prostate cancer cells. Cancer Res 63: 2665-2674.
27. Cocquerel L, Quinn ER, Flint M, Hadlock KG, Foung SK, et al. (2003) Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody. J Virol 77: 1604-1609.
28. Higginbottom A, Quinn ER, Kuo CC, Flint M, Wilson LH, et al. (2000) Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol 74: 3642-3649.
29. Kazarov AR, Yang X, Stipp CS, Sehgal B, Hemler ME (2002) An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology. J Cell Biol 158: 1299-1309.
30. Yang XH, Kovalenko OV, Kolesnikova TV, Andzelm MM, Rubinstein E, et al. (2006) Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization. J Biol Chem 281: 12976-12985.
31. Kapadia SB, Barth H, Baumert T, McKeating JA, Chisari FV (2007) Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type 1. J Virol 81: 374-383.
32. Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R, Pietschmann T (2007) The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol 81: 588-598.
33. Molina S, Castet V, Pichard-Garcia L, Wychowski C, Meurs E, et al. (2008) Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol 82: 569-574.
34. Cormier EG, Tsamis F, Kajumo F, Durso RJ, Gardner JP, et al. (2004) CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci U S A 101: 7270-7274.
35. Flint M, von Hahn T, Zhang J, Farquhar M, Jones CT, et al. (2006) Diverse CD81 proteins support hepatitis C virus infection. J Virol 80: 11331-11342.
36. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, et al. (2006) Characterization of the early steps of hepadds C virus infection by using luciferase reporter viruses. J Virol 80: 5308-5320.
37. Meertens L, Bertaux C, Cukierman L, Cormier E, Lavillette D, et al. (2008) The tight junction proteins claudin-1, -6 and -9 are entry cofactors for the Hepatitis C virus. J Virol.
38. Bost AG, Venable D, Liu L, Heinz BA (2003) Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system. J Virol 77: 4401-4408.
39. Coffey G, Kuo C-C, Levy S. Co-ligation of CD81 and the B-cell receptor by Hepatitis C Virus envelope protein E2 enhances B-cell signaling. In: Conferences FSR, ed. 2006; Tucson, AZ, USA.
40. Crotta S, Ronconi V, Ulivieri C, Baldari CT, Valiante NM, et al. (2006) Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells. Eur J Immunol 36: 919-929.
41. Cocquerel L, Voisset C, Dubuisson J (2006) Hepatitis C virus entry: potential receptors and their biological functions. J Gen Virol 87: 1075-1084.
42. Cocquerel L, Kuo CC, Dubuisson J, Levy S (2003) CD81-dependent binding of hepatitis C virus E1E2 heterodimers. J Virol 77: 10677-10683.
43. Oren R, Takahashi S, Doss C, Levy R, Levy S (1990) TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 10: 4007-4015.
44. Cocquerel L, Meunier JC, Pillez A, Wychowski C, Dubuisson J (1998) A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J Virol 72: 2183-2191.
45. Flint M, Maidens C, Loomis-price LD, Shotton C, Dubuisson J, et al. (1999) Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 73: 6235-6244.
46. Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, et al. (2001) Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol 75: 8240-8250.
47. Delgrange D, Pillez A, Castelain S, Cocquerel L, Rouille Y, et al. (2007) Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J Gen Virol 80: 2495-2503.
48. Tscheme DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, et al. (2006) Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 80: 1734-1741.
49. Kato T, Date T, Miyamoto, M, Furusaka A, Tokushige, K, et al. (2003) Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125: 1808-1817.
50. Op De Beeck A, Voisset-C, Bartosch B, Ciczora Y, Cocquerel L, et al. (2004) Characterization of functional hepatitis C virus envelope glycoproteins. J Virol 78: 2994-3002.
51. Sandrin V, Boson B, Salmon P, Gay W, Negre D, et al. (2002) Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 100: 823-832.